跳至主要内容
临床试验/CTRI/2026/01/100954
CTRI/2026/01/100954尚未招募2/3 期

Randomized Controlled Clinical Study To Evaluate The Efficacy Of Lashunadi Vati In The Management Of Udavartini Yonivyapad With Special Reference To Primary Dysmenorrhoea

Dr Shivani Ravindra Tuptewar1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2026年2月10日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
110
试验地点
1

研究概览

简要总结

This Study is Randomized Open Labelled Controlled Clinical Trial Comparing  the Safety and Efficacy of Lashunadi Vati 250 mg BD With Koshna Jal Before Meal And Controlled Drug Rajapravartini Vati 250 mg BD With Koshna Jal Before Meal For 3 Consecutive Menstrual Cycles in 110 Patient of Udavartini Yonivyapad Divided In 2 Groups And Observed VAS NRS Scale.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 25.00 Year(s)(—)
性别
Female

入选标准

  • 1.Patients on hormonal therapy.
  • 2.Pelvic Inflammatory Disease, uterine fibroid, Adenomyosis.
  • 3.Known case of structural anomalies of genital tract.
  • 4.Known case of immune compressive diseases like HIV, HBsAg.

排除标准

  • Patients on hormonal therapy.
  • Pelvic Inflammatory Disease, uterine fibroid, Adenomyosis.
  • Known case of structural anomalies of genital tract.
  • Known case of immune compressive diseases like HIV , HBsAg.
  • Known case of life style disorders like DM, HTN, PCOD, Thyroid abnormalities.

研究者

发起方
Dr Shivani Ravindra Tuptewar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Shivani Ravindra Tuptewar

Siddhakala Ayurveda college and research center sangamner

研究点 (1)

Loading locations...

相似试验

To evaluate the drug efficacy of lashunadi vati in... | 临床试验